Lastly, we found that the drugs that inhibit HA synthesis reduced metastatic tumor burden in steatotic liver in mice, and enhanced antitumor response when added to anti–programmed cell death protein 1 (anti–PD-1) therapy. The gene discussed is PDCD1; the disease is neoplasm.